# TherapeuticsMD, Inc.: Form SC 13D/A, filed Aug 30, 2022

- Company: [TherapeuticsMD, Inc.](/companies/txmd.md) (CIK 25743)
- Form: SC 13D/A
- Filed: 2022-08-30
- Accepted by EDGAR: Aug 30, 2022, 09:09 ET
- Period: not reported
- Accession: 0001104659-22-095856
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/25743/000110465922095856/tm2224805-1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/25743/000110465922095856/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/25743/000110465922095856/tm2224805-1_sc13da.htm

Filed Aug 30, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-095856. Last ingested by Listed: Nov 14, 2026, 19:24 ET. No prices; not investment advice.
